# Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)

> **NCT03855189** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 345 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Mometasone Furoate (MF)
- **DRUG:** Beclomethasone Dipropionate (BDP)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03855189
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-08-23
- **Primary completion:** 1993-10-08
- **Final completion:** 1993-10-22
- **Target enrollment:** 345 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03855189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03855189, "Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03855189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*